HOME >> MEDICINE >> NEWS
FDA approves Actonel for once-a-week use

Cincinnati, Ohio; Bridgewater, N.J. (May 20, 2002) - The FDA has approved a new 35 mg once-a-week dosage strength for Actonel (risedronate sodium tablets) for the prevention and treatment of postmenopausal osteoporosis. This approval offers patients the convenience of a once-a-week dosing option to manage their osteoporosis and protect their bones. It will be available in mid-June 2002, by prescription only.

Actonel 35 mg once-a-week is a valuable new tool for the treatment and prevention of postmenopausal osteoporosis, said Robert Lindsay, M.D., Ph.D., Chief of Internal Medicine at Helen Hayes Hospital, Professor of Clinical Medicine, Columbia University, and principal investigator of the Actonel once-a-week approval study. Patients and doctors always welcome effective new treatment choices, and we now have data that show once-a-week dosing of Actonel is therapeutically equivalent to daily 5 mg dosing."

The FDA based its approval on safety and efficacy data from a one-year, double-blind, multicenter study that included 1,456 postmenopausal women with osteoporosis and compared the effects of the once-a-week and daily dosing of Actonel on bone mineral density (BMD). Patients taking Actonel 35 mg once-a-week experienced a significant increase in lumbar spine BMD at 12 months versus baseline -- an increase that was similar to that achieved with the Actonel 5 mg daily dose. There was also a significant increase in BMD versus baseline at the hip at 12 months, an increase that was similar in both treatment groups.

The overall safety and tolerability profiles of Actonel 35 mg once-a-week and 5 mg daily were similar in the study. Consistent with other pivotal Actonel clinical studies, patients were not excluded based on a history of, or active, GI disease.


'"/>

Contact: Ashley Donnelly
adonnelly@hillandknowlton.com
212-885-0488
Hill and Knowlton
20-May-2002


Page: 1

Related medicine news :

1. FDA approves Pfizers Lyrica for the treatment of the two most common forms of neuropathic pain
2. FDA approves Enablex for treatment of overactive bladder
3. FDA approves Fosrenol(R) in end-stage renal disease (ESRD) patients
4. FDA approves Adderall XR (R) to treat ADHD in adults
5. FDA approves EPZICOM
6. FDA approves new labelling for Seroquel in bioplar mania
7. FDA approves Enbrel to treat psoriasis
8. FDA approves Climara Pro to treat menopause symptoms
9. FDA approves new approach to schizophrenia treatment
10. FDA approves new HIV protease inhibitor, Lexiva (TM)
11. FDA approves Wellbutrin XL(TM)

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/11/2018)... ... November 09, 2018 , ... ... has joined the #GivingTuesday movement. Kicking off the giving season, #GivingTuesday is an ... the widely recognized shopping events Black Friday and Cyber Monday. , ACMA’s ...
(Date:11/11/2018)... ... 11, 2018 , ... Cortney Afton, registered dietitian and nutrition care coordinator for ... a positive impact on the lives of her consumers. “Every day when I leave ... many wonderful resources in Kalamazoo and this Mobile Kitchen initiative is one of them.” ...
(Date:11/9/2018)... ... November 09, 2018 , ... Bio-Logic Aqua® Research ... for dry eye that restores lipids and proteins to the aqueous layer of ... on Youtube from founder Sharon Kleyne and Bio-Logic Aqua® Research Water Life Science® ...
(Date:11/9/2018)... ... November 08, 2018 , ... Achla Karnani is ... , Caring Transitions’ specially-trained team can handle organizing, packing, de-cluttering, moving, resettling, in-person ... in assisting seniors, but their services are great for any families or individuals ...
(Date:11/8/2018)... ... November 08, 2018 , ... How ... different media sources could impact how they view advertising and earned media in ... Connections, Inc. will release results of the tenth annual study of the media ...
Breaking Medicine News(10 mins):
(Date:11/13/2018)... ... November 13, 2018 , ... ... pioneer in cloud computing , today announced that LifeNet Health , ... process. Esker’s cloud-based AP solution is integrated with the company’s SAP® ...
(Date:11/13/2018)... , ... November 13, 2018 , ... ... microbial genomics, has awarded microbiome research support in study design, planning, sample collection, ... by Dr. Marc Braunstein, PhD, MD, Assistant Professor of Clinical Medicine, to compare ...
(Date:11/13/2018)... ... 13, 2018 , ... New Cleveland Clinic Study Shows Bariatric ... undergone weight-loss or bariatric surgery, and later suffer unrelated heart failure, cut their ... according to a new study from Cleveland Clinic researchers who presented their ...
Breaking Medicine Technology:
Cached News: